Back to search
FDAFDA · Food and drugs·Recall number D-397-2014

Carisoprodol Tablets, USP, CIV, 350 mg, 500 count bottle, Rx only. Manufactured by Watson Pharma Private Ltd, Verna, Salcette, Goa, 403 722 INDIA. Distributed by: Watson Pharma Ltd, Parsippany, NJ 07054. NDC 0591-5513-05.

Published January 15, 2014 · Recall initiated: December 23, 2013

Summary

FDA records drug Class II recall D-397-2014, published January 15, 2014 and initiated December 23, 2013. Recalling firm: Watson Laboratories Inc; Status: Terminated; Reported quantity: 4,439 bottles; Lot: Lot # 244152A, exp 01/15. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Foreign Substance; metal particulates were visually observed in the tablets.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Watson Laboratories Inc
Distributor
Nationwide
Lot
Lot # 244152A, exp 01/15.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Carisoprodol Tablets, USP, CIV, 350 mg, 500 count bottle, Rx only. Manufactured by Watson Pharma Private Ltd, Verna, Salcette, Goa, 403 722 INDIA. Distributed by: Watson Pharma Ltd, Parsippany, NJ 07054. NDC 0591-5513-05. recalled?

Yes. FDA published recall D-397-2014 on January 15, 2014. Reported hazard: Presence of Foreign Substance; metal particulates were visually observed in the tablets.

What should I do if I have this product?

Voluntary: Firm initiated · Letter